Rheumatoid arthritis is a chronic inflammatory disorder that mainly affects the joints. Individuals with rheumatoid arthritis are at an increased risk of cardiovascular disease, including peripheral arterial disease (PAD).
PAD is a common vascular condition characterized by a narrowing or blockage of the arteries, typically in the legs, leading to decreased blood flow to the affected area.
Overview of rheumatoid arthritis
Rheumatoid arthritis is an autoimmune disease that causes the immune system to attack the body’s own healthy cells and tissues.
The main target of this attack is the synovial tissue lining the joints, leading to inflammation and eventually destruction of the joint. The condition affects approximately 1% of the global population, with a higher prevalence in women than men and typically diagnosed between the ages of 30 and 50.
Rheumatoid arthritis is a systemic disease, meaning it can affect other organs besides the joints. Patients can experience fatigue, fever, and weight loss.
In addition, they are also at a higher risk of developing cardiovascular disease, particularly atherosclerosis.
Overview of peripheral arterial disease
PAD is a common vascular condition that affects around 200 million people globally. PAD occurs when the arteries that supply blood to the limbs, typically the legs, narrow or become blocked by a buildup of plaque (fatty deposits).
The plaque buildup leads to decreased blood flow to the affected area, which can cause leg pain, weakness, numbness, tingling, and in severe cases, tissue death (gangrene).
PAD is often a silent disease with no symptoms until advanced stages. Therefore, early diagnosis and treatment are critical to preventing complications, including the loss of limb or death due to cardiovascular events.
The link between rheumatoid arthritis and peripheral arterial disease
Several studies have identified an association between rheumatoid arthritis and PAD. Patients with rheumatoid arthritis are twice more likely to develop PAD compared to the general population.
Furthermore, the incidence of PAD in rheumatoid arthritis patients is higher in those with longer disease durations, indicating a link between chronic inflammation and the development of PAD.
Inflammation is a key driver of atherosclerosis, the underlying cause of PAD.
The systemic inflammation associated with rheumatoid arthritis increases the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). These cytokines lead to endothelial dysfunction (a narrowing of blood vessels) and platelet activation, initiating the formation of atherosclerotic plaque.
Factors that increase the risk of peripheral arterial disease in rheumatoid arthritis patients
Several factors can increase the risk of PAD in patients with rheumatoid arthritis, including:.
- Smoking: Smoking is a major risk factor for PAD in both the general population and rheumatoid arthritis patients. It accelerates atherosclerosis by damaging the endothelial lining of blood vessels, increasing inflammation, and promoting platelet activation.
- Disease duration: Patients with longer disease durations are at a higher risk of developing PAD, possibly due to the cumulative effect of chronic inflammation on the endothelium.
- Disease activity: Patients with active rheumatoid arthritis, as indicated by higher levels of inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), are at increased risk of PAD. The inflammatory process increases the production of pro-inflammatory cytokines, leading to endothelial dysfunction and atherosclerosis.
- Obesity: Obesity is a risk factor for atherosclerosis and PAD. In addition, obesity is associated with higher levels of inflammatory markers and insulin resistance, which can contribute to the development of PAD in rheumatoid arthritis patients.
- Hypertension: Hypertension is a risk factor for atherosclerosis and PAD, and it’s more common in rheumatoid arthritis patients than in the general population. Hypertension damages the endothelium, leading to atherosclerosis.
- Dyslipidemia: Dyslipidemia, or abnormal lipid levels (e.g. high levels of LDL cholesterol), is a major risk factor for atherosclerosis and PAD. Rheumatoid arthritis patients may have dyslipidemia due to chronic inflammation and the use of medications such as corticosteroids.
Diagnosis and management of peripheral arterial disease in rheumatoid arthritis patients
The diagnosis of PAD in rheumatoid arthritis patients involves a physical examination, pulse palpation (checking the pulses in the legs), ankle-brachial index (ABI) measurement, and imaging tests such as duplex ultrasonography or angiography.
The management of PAD in rheumatoid arthritis patients involves lifestyle modifications, medications, and interventions such as endovascular procedures or surgery. Lifestyle modifications include smoking cessation, weight loss, and regular exercise.
Medications typically include antiplatelet agents (e.g. aspirin) and lipid-lowering agents (e.g. statins). Endovascular procedures include balloon angioplasty or stent placement to open up blocked vessels. Surgery may be necessary in severe cases.
Conclusion
Rheumatoid arthritis and peripheral arterial disease are two conditions that share an inflammatory component.
Patients with rheumatoid arthritis are at an increased risk of PAD due to chronic inflammation, disease activity, and other risk factors such as smoking and obesity. Early diagnosis and management of PAD in rheumatoid arthritis patients are critical to prevent complications such as limb loss or death due to cardiovascular events.